Читать книгу Sarcopenia - Группа авторов - Страница 24

1 1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127:990–991.

2 2. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147:755–763.

3 3. Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009; 90:1579–1585.

4 4. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010; 1(2):129–133.

5 5. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well‐functioning older persons. J Gerontol Biol Sci Med Sci. 2005; 60:324–333.

6 6. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol Biol Sci Med Sci. 2006; 61:72–77.

7 7. Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol Biol Sci Med Sci. 2006; 61:1059–1064.

8 8. Clark BC, Manini TM. Sarcopenia = / = dynapenia. J Gerontol Biol Sci Med Sci. 2008; 63:829–834.

9 9. Evans WJ, Hellerstein M, Orwoll E, Cummings S, Cawthon PM. D3 ‐creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass. J Cachexia Sarcopenia Muscle. 2019; 10(1):14–21.

10 10. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011; 12:403–409.

11 11. Fearon K, Evans WJ, Anker SD. Myopenia‐a new universal term for muscle wasting. J Cachex Sarcopenia Muscle. 2011; 2:1–3.

12 12. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre‐cachexia: joint document elaborated by Special Interest Groups (SIG) ‘cachexia‐anorexia in chronic wasting diseases’ and ‘nutrition in geriatrics. Clin Nutr. 2010; 29(2):154–159.

13 13. Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39:412–423.

14 14. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011; 12(4):249–256.

15 15. Chen L‐K, Liu L‐K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95–101.

16 16. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014; 69(5):547–558.

17 17. Anker SD, Morley JE, von Haehling S. Welcome to the ICD‐10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016; 7(5):512–514.

18 18. Dent E, Morley JE, Cruz‐Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018; 22(10):1148–1161.

19 19. Le Lain R, Ignaszewski C, Klingmann I, Cesario A, de Boer WI, SPRINTT Consortium. SPRINTT and the involvement of stakeholders: strategy and structure. Aging Clin Exp Res. 2017; 29(1):65–67.

20 20. Cruz‐Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1):16–31.

21 21. Cruz‐Jentoft AJ. Sarcopenia, the last organ insufficiency. Eur Geriatr Med. 2020; 75(7):1317–1323.

22 22. Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, et al. Evidence for the domains supporting the construct of intrinsic capacity. J Gerontol A Biol Sci Med Sci. 2018; 73(12):1653–1660.

23 23. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020; 21(3):300–307.e2.

24 24. Zanker J, Scott D, Reijnierse EM, et al. Establishing an operational definition of sarcopenia in Australia and New Zealand: Delphi method based consensus statement. J Nutr Health Aging. 2019; 23(1):105–110.

25 25. Bauer J, Morley JE, Schols AMWJ, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019; 10(5):956–961.

26 26. Cawthon PM, Travison TG, Manini TM, et al. Establishing the link between lean mass and grip strength cut‐points with mobility disability and other health outcomes: proceedings of the sarcopenia definition and outcomes consortium conference. J Gerontol A Biol Sci Med Sci. 2020; 75(7):1317–1323.

27 27. Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020; 68(7):1410–1418.

28 28. Carey EJ, Lai JC, Sonnenday C, et al. A North American expert opinion statement on sarcopenia in liver transplantation. Hepatology 2019; 70(5):1816–1829.

29 29. Ooi PH, Thompson‐Hodgetts S, Pritchard‐Wiart L, Gilmour SM, Mager DR. Pediatric sarcopenia: a paradigm in the overall definition of malnutrition in children? JPEN J Parenter Enteral Nutr. 2020; 44(3):407–418.

30 30. Bauer JM, Cruz‐Jentoft AJ, Fielding RA, et al. Is there enough evidence for osteosarcopenic obesity as a distinct entity? A critical literature review. Calcif Tissue Int. 2019; 105(2):109–124.

31 31. Nielsen BR, Abdulla J, Andersen HE, Schwarz P, Suetta C. Sarcopenia and osteoporosis in older people: a systematic review and meta‐analysis. Eur Geriatr Med. 2018; 9(4):419–434.

32 32. Edwards MH, Dennison EM, Aihie Sayer A, Fielding R, Cooper C. Osteoporosis and sarcopenia in older age. Bone. 2015; 80:126–130.

33 33. He H, Liu Y, Tian Q, Papasian CJ, Hu T, Deng H‐W. Relationship of sarcopenia and body composition with osteoporosis. Osteoporos Int. 2016; 27(2):473–482.

34 34. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004; 12(12):1995–2004.

35 35. Donini L. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2020; 39(8):2368–2388.

36 36. Scott D, Hirani V. Sarcopenic obesity. Eur Geriatr Med. 2016; 7(3):214–219.

37 37. Barazzoni R, Bischoff SC, Boirie Y, et al. Sarcopenic obesity: time to meet the challenge. Clin Nutr. 2018; 37(6 Pt A):1787–1793.

38 38. Jeejeebhoy KN. Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Curr Opin Clin Nutr Metab Care. 2012; 15(3):213–219.

39 39. Ter Beek L, Vanhauwaert E, Slinde F, et al. Unsatisfactory knowledge and use of terminology regarding malnutrition, starvation, cachexia and sarcopenia among dietitians. Clin Nutr. 2016; 35(6):1450–1456.

40 40. Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition ‐ a consensus report from the global clinical nutrition community. Clin Nutr. 2019; 38(1):1–9.

41 41. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489–495

42 42. Peterson SJ, Mozer M. Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017; 32(1):30–39.

43 43. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001; 56:146–156.

44 44. Morley JE. Frailty and sarcopenia: the new geriatric giants. Rev Investig Clin. 2016; 68(2):59–67.

45 45. Cruz‐Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019; 393(10191):2636–2646.

46 46. Dent E, Lien C, Lim WS, et al. The Asia‐Pacific clinical practice guidelines for the management of frailty. J Am Med Dir Assoc. 2017; 18(7):564–575.

47 47. Dent E, Morley JE, Cruz‐Jentoft AJ, et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging. 2019; 23(9):771–787.

48 48. Ram CVS, Giles TD. The evolving definition of systemic arterial hypertension. Curr Atheroscler Rep. 2010; 12(3):155–158.

49 49. Słodki M, Respondek‐Liberska M, Pruetz JD, Donofrio MT. Fetal cardiology: changing the definition of critical heart disease in the newborn. J Perinatol. 2016; 36(8):575–580.

50 50. Louis ED. The evolving definition of essential tremor: what are we dealing with? Parkinsonism Relat Disord. 2018; 46(Suppl 1):S87–S91.

51 51. Beaudart C, Rolland Y, Cruz‐Jentoft AJ, et al. Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int. 2019; 105(1):1–14.

52 52. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016; 7(1):28–36.